Skip to content

Hepcidin Levels in Periodontal Health and Disease

Gingival Crevicular Fluid and Serum Levels of Hepcidin, IL-6 and IL-10 in Periodontal Health and Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03789565
Enrollment
90
Registered
2018-12-28
Start date
2017-03-15
Completion date
2018-02-15
Last updated
2019-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Keywords

periodontal diseases, hepcidin, elisa, interleukin 6, interleukin 10

Brief summary

Periodontal disease refers to inflammatory disease of the periodontium caused by the host and/or pathogenic microorganisms. Anti-inflammatory and pro-inflammatory cytokines play a role in the periodontal inflammation process. The aim of this study was to evaluate the levels of hepcidin, interleukin (IL)-6, and IL-10 levels in gingival crevicular fluid (GCF) and in serum samples obtained from individuals with periodontal inflammation.

Detailed description

The study included 90 individuals, who were divided into three groups: periodontally healthy (PH) (n=30); gingivitis (G) (n=30); and chronic periodontitis (CP) (n=30). GCF and serum samples were obtained from each individual, and samples were evaluated using ELISA. Statistical evaluation of the data was performed using the SPSS packet data program.

Interventions

Diagnostic biomarker study

Sponsors

Bulent Ecevit University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
32 Years to 52 Years

Inclusion criteria

* Systematically healthy patients. Patients who did not receive any medication or periodontal treatment within the previous 6 months

Exclusion criteria

* Individuals who smoked and women who were pregnant and/or lactating were excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
Hepcidin levels1 yearChange in inflammatory phases

Secondary

MeasureTime frameDescription
IL-6 levels1 yearChange in inflammatory phases
IL-10 levels1 yearChange in inflammatory phases

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026